Exact Mass: 567.289076
Exact Mass Matches: 567.289076
Found 500 metabolites which its exact mass value is equals to given mass value 567.289076
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nelfinavir
C32H45N3O4S (567.3130610000001)
Nelfinavir is only found in individuals that have used or taken this drug. It is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. [PubChem]Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
LysoPC(22:6/0:0)
LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of docosahexaenoic acid at the C-1 position. The docosahexaenoic acid moiety is derived from fish oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)), in particular, consists of one chain of docosahexaenoic acid at the C-1 position. The docosahexaenoic acid moiety is derived from fish oils. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
4-Hprog
4-[[4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]-2,3-dimethylbenzoyl]-methylamino]-5-methoxy-2,2,3,3,4-pentamethyl-5-oxopentanoic acid
3,5-bis(3-methyl-2-butenyl)-4-O-[beta-D-glucopyranosyl-(1?2)-alpha-L-arabinopyranosyl]benzamide
C28H41NO11 (567.2679476000001)
(6R,8E,13E,15E)-17t-acetoxy-6r-isopropyl-7c,15-dimethyl-34,5-dihydro-5-oxa-11-aza-1(4,2)-oxazola-3(1,2)-pyrrola-cycloeicosaphane-8,13,15-triene-2,4,10,19-tetraone|O14-acetyl-virginiamycin-M1|Pristinamycin II A- acetat
C30H37N3O8 (567.2580522000001)
Arg Tyr Thr Glu
Nelfinavir
C32H45N3O4S (567.3130610000001)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Cys Phe Ile Trp
Cys Phe Leu Trp
Cys Phe Trp Ile
Cys Phe Trp Leu
Cys Ile Phe Trp
Cys Ile Trp Phe
Cys Leu Phe Trp
Cys Leu Trp Phe
Cys Trp Phe Ile
Cys Trp Phe Leu
Cys Trp Ile Phe
Cys Trp Leu Phe
Asp Phe Met Arg
Asp Phe Arg Met
Asp Met Phe Arg
Asp Met Arg Phe
Asp Arg Phe Met
Asp Arg Met Phe
Glu Glu Lys Tyr
Glu Glu Tyr Lys
Glu His Pro Trp
Glu His Trp Pro
Glu Lys Glu Tyr
Glu Lys Tyr Glu
Glu Pro His Trp
Glu Pro Trp His
Glu Arg Thr Tyr
Glu Arg Tyr Thr
Glu Thr Arg Tyr
Glu Thr Tyr Arg
Glu Trp His Pro
Glu Trp Pro His
Glu Tyr Glu Lys
Glu Tyr Lys Glu
Glu Tyr Arg Thr
Glu Tyr Thr Arg
Phe Cys Ile Trp
Phe Cys Leu Trp
Phe Cys Trp Ile
Phe Cys Trp Leu
Phe Asp Met Arg
Phe Asp Arg Met
Phe Phe Arg Val
Phe Phe Val Arg
Phe His His Lys
Phe His His Gln
Phe His Lys His
Phe His Gln His
Phe Ile Cys Trp
Phe Ile Trp Cys
Phe Lys His His
Phe Leu Cys Trp
Phe Leu Trp Cys
Phe Met Asp Arg
Phe Met Arg Asp
Phe Gln His His
Phe Arg Asp Met
Phe Arg Phe Val
Phe Arg Met Asp
Phe Arg Val Phe
Phe Val Phe Arg
Phe Val Arg Phe
Phe Trp Cys Ile
Phe Trp Cys Leu
Phe Trp Ile Cys
Phe Trp Leu Cys
His Phe His Lys
His Phe His Gln
His Phe Lys His
His Phe Gln His
His His Phe Lys
His His Phe Gln
His His Lys Phe
His His Gln Phe
His Ile Ile Trp
His Ile Leu Trp
His Ile Trp Ile
His Ile Trp Leu
His Lys Phe His
His Lys His Phe
His Lys Gln Arg
His Lys Arg Gln
His Leu Ile Trp
His Leu Leu Trp
His Leu Trp Ile
His Leu Trp Leu
His Gln Phe His
His Gln His Phe
His Gln Lys Arg
His Gln Gln Arg
C22H37N11O7 (567.2877292000001)
His Gln Arg Lys
His Gln Arg Gln
C22H37N11O7 (567.2877292000001)
His Arg Lys Gln
His Arg Gln Lys
His Arg Gln Gln
C22H37N11O7 (567.2877292000001)
His Trp Ile Ile
His Trp Ile Leu
His Trp Leu Ile
His Trp Leu Leu
Ile Cys Phe Trp
Ile Cys Trp Phe
Ile Phe Cys Trp
Ile Phe Trp Cys
Ile His Ile Trp
Ile His Leu Trp
Ile His Trp Ile
Ile His Trp Leu
Ile Ile His Trp
Ile Ile Trp His
Ile Leu His Trp
Ile Leu Trp His
Ile Ser Trp Tyr
Ile Ser Tyr Trp
Ile Trp Cys Phe
Ile Trp Phe Cys
Ile Trp His Ile
Ile Trp His Leu
Ile Trp Ile His
Ile Trp Leu His
Ile Trp Ser Tyr
Ile Trp Tyr Ser
Ile Tyr Ser Trp
Ile Tyr Trp Ser
Lys Glu Glu Tyr
Lys Glu Tyr Glu
Lys Phe His His
Lys His Phe His
Lys His His Phe
Lys His Gln Arg
Lys His Arg Gln
Lys Gln His Arg
Lys Gln Arg His
Lys Arg His Gln
Lys Arg Gln His
Lys Tyr Glu Glu
Leu Cys Phe Trp
Leu Cys Trp Phe
Leu Phe Cys Trp
Leu Phe Trp Cys
Leu His Ile Trp
Leu His Leu Trp
Leu His Trp Ile
Leu His Trp Leu
Leu Ile His Trp
Leu Ile Trp His
Leu Leu His Trp
Leu Leu Trp His
Leu Ser Trp Tyr
Leu Ser Tyr Trp
Leu Trp Cys Phe
Leu Trp Phe Cys
Leu Trp His Ile
Leu Trp His Leu
Leu Trp Ile His
Leu Trp Leu His
Leu Trp Ser Tyr
Leu Trp Tyr Ser
Leu Tyr Ser Trp
Leu Tyr Trp Ser
Met Asp Phe Arg
Met Asp Arg Phe
Met Phe Asp Arg
Met Phe Arg Asp
Met Arg Asp Phe
Met Arg Phe Asp
Met Arg Val Tyr
C25H41N7O6S (567.2838886000001)
Met Arg Tyr Val
C25H41N7O6S (567.2838886000001)
Met Val Arg Tyr
C25H41N7O6S (567.2838886000001)
Met Val Tyr Arg
C25H41N7O6S (567.2838886000001)
Met Tyr Arg Val
C25H41N7O6S (567.2838886000001)
Met Tyr Val Arg
C25H41N7O6S (567.2838886000001)
Gln Phe His His
Gln His Phe His
Gln His His Phe
Gln His Lys Arg
Gln His Gln Arg
C22H37N11O7 (567.2877292000001)
Gln His Arg Lys
Gln His Arg Gln
C22H37N11O7 (567.2877292000001)
Gln Lys His Arg
Gln Lys Arg His
Gln Gln His Arg
C22H37N11O7 (567.2877292000001)
Gln Gln Arg His
C22H37N11O7 (567.2877292000001)
Gln Arg His Lys
Gln Arg His Gln
C22H37N11O7 (567.2877292000001)
Gln Arg Lys His
Gln Arg Gln His
C22H37N11O7 (567.2877292000001)
Arg Asp Phe Met
Arg Asp Met Phe
Arg Glu Thr Tyr
Arg Glu Tyr Thr
Arg Phe Asp Met
Arg Phe Phe Val
Arg Phe Met Asp
Arg Phe Val Phe
Arg His Lys Gln
Arg His Gln Lys
Arg His Gln Gln
C22H37N11O7 (567.2877292000001)
Arg Lys His Gln
Arg Lys Gln His
Arg Met Asp Phe
Arg Met Phe Asp
Arg Met Val Tyr
C25H41N7O6S (567.2838886000001)
Arg Met Tyr Val
C25H41N7O6S (567.2838886000001)
Arg Gln His Lys
Arg Gln His Gln
C22H37N11O7 (567.2877292000001)
Arg Gln Lys His
Arg Gln Gln His
C22H37N11O7 (567.2877292000001)
Arg Thr Glu Tyr
Arg Thr Tyr Glu
Arg Val Phe Phe
Arg Val Met Tyr
C25H41N7O6S (567.2838886000001)
Arg Val Tyr Met
C25H41N7O6S (567.2838886000001)
Arg Tyr Glu Thr
Arg Tyr Met Val
C25H41N7O6S (567.2838886000001)
Arg Tyr Val Met
C25H41N7O6S (567.2838886000001)
Ser Ile Trp Tyr
Ser Ile Tyr Trp
Ser Leu Trp Tyr
Ser Leu Tyr Trp
Ser Trp Ile Tyr
Ser Trp Leu Tyr
Ser Trp Tyr Ile
Ser Trp Tyr Leu
Ser Tyr Ile Trp
Ser Tyr Leu Trp
Ser Tyr Trp Ile
Ser Tyr Trp Leu
Thr Glu Arg Tyr
Thr Glu Tyr Arg
Thr Arg Glu Tyr
Thr Arg Tyr Glu
Thr Val Trp Tyr
Thr Val Tyr Trp
Thr Trp Val Tyr
Thr Trp Tyr Val
Thr Tyr Glu Arg
Thr Tyr Arg Glu
Thr Tyr Val Trp
Thr Tyr Trp Val
Val Phe Phe Arg
Val Phe Arg Phe
Val Met Arg Tyr
C25H41N7O6S (567.2838886000001)
Val Met Tyr Arg
C25H41N7O6S (567.2838886000001)
Val Arg Phe Phe
Val Arg Met Tyr
C25H41N7O6S (567.2838886000001)
Val Arg Tyr Met
C25H41N7O6S (567.2838886000001)
Val Thr Trp Tyr
Val Thr Tyr Trp
Val Trp Thr Tyr
Val Trp Tyr Thr
Val Tyr Met Arg
C25H41N7O6S (567.2838886000001)
Val Tyr Arg Met
C25H41N7O6S (567.2838886000001)
Val Tyr Thr Trp
Val Tyr Trp Thr
Trp Cys Phe Ile
Trp Cys Phe Leu
Trp Cys Ile Phe
Trp Cys Leu Phe
Trp Phe Cys Ile
Trp Phe Cys Leu
Trp Phe Ile Cys
Trp Phe Leu Cys
Trp His Ile Ile
Trp His Ile Leu
Trp His Leu Ile
Trp His Leu Leu
Trp Ile Cys Phe
Trp Ile Phe Cys
Trp Ile His Ile
Trp Ile His Leu
Trp Ile Ile His
Trp Ile Leu His
Trp Ile Ser Tyr
Trp Ile Tyr Ser
Trp Leu Cys Phe
Trp Leu Phe Cys
Trp Leu His Ile
Trp Leu His Leu
Trp Leu Ile His
Trp Leu Leu His
Trp Leu Ser Tyr
Trp Leu Tyr Ser
Trp Ser Ile Tyr
Trp Ser Leu Tyr
Trp Ser Tyr Ile
Trp Ser Tyr Leu
Trp Thr Val Tyr
Trp Thr Tyr Val
Trp Val Thr Tyr
Trp Val Tyr Thr
Trp Tyr Ile Ser
Trp Tyr Leu Ser
Trp Tyr Ser Ile
Trp Tyr Ser Leu
Trp Tyr Thr Val
Trp Tyr Val Thr
Tyr Glu Glu Lys
Tyr Glu Lys Glu
Tyr Glu Arg Thr
Tyr Glu Thr Arg
Tyr Ile Ser Trp
Tyr Ile Trp Ser
Tyr Lys Glu Glu
Tyr Leu Ser Trp
Tyr Leu Trp Ser
Tyr Met Arg Val
C25H41N7O6S (567.2838886000001)
Tyr Met Val Arg
C25H41N7O6S (567.2838886000001)
Tyr Arg Glu Thr
Tyr Arg Met Val
C25H41N7O6S (567.2838886000001)
Tyr Arg Thr Glu
Tyr Arg Val Met
C25H41N7O6S (567.2838886000001)
Tyr Ser Ile Trp
Tyr Ser Leu Trp
Tyr Ser Trp Ile
Tyr Ser Trp Leu
Tyr Thr Glu Arg
Tyr Thr Arg Glu
Tyr Thr Val Trp
Tyr Thr Trp Val
Tyr Val Met Arg
C25H41N7O6S (567.2838886000001)
Tyr Val Arg Met
C25H41N7O6S (567.2838886000001)
Tyr Val Thr Trp
Tyr Val Trp Thr
Tyr Trp Ile Ser
Tyr Trp Leu Ser
Tyr Trp Ser Ile
Tyr Trp Ser Leu
Tyr Trp Thr Val
Tyr Trp Val Thr
PC(22:6/0:0)[U]
PC(22:6/0:0)
Didecanoylphosphatidylserine
cataCXium(R) FPrPh,Dicyclohexyl[9-(3-phenylpropyl)-9-fluorenyl]phosphine tetrafluoroborate
C34H41BF4P (567.2974893999999)
5-DMT-N6-Me-2-dA
C32H33N5O5 (567.2481568000001)
5'-O-DMT-N6-Me-2'-dA is a nucleoside with protective and modification effects.
(alphaS)-alpha-Aminobenzenebutanoyl-L-leucyl-L-phenylalanine methyl ester mono(trifluoroacetate)
HG-9-91-01
(S)-2-((9-([1,1-biphenyl]-4-ylmethyl)-2-((2,3-dihydro-1H-inden-5-yl)oxy)-9H-purin-6-yl)amino)-3-phenylpropan-1-ol
3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4,5-dihydro-3H-1-benzazepin-3-yl]butanamide
rel-sodium 2-((1S,4R,5aS,5bR,7aS,11aS,11bR,13R,13aS)-13-acetoxy-1,4-dimethoxy-5b,8,8,11a,13a-pentamethyl-3-oxo-5,5a,6,7,7a,8,9,10,11,11a,11b,12,13,13a-tetradecahydro-1H-phenanthro[2,1-e]isoindol-2(3H,4H,5bH)-yl)acetate
A natural product found in Hyattella species.
2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:6 in which the acyl group is specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl and is located at position 2.
1-O-(3alpha,7alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)-beta-D-glucopyranuronate
1-O-(3alpha,12alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)-beta-D-glucopyranuronate
1-O-(3alpha,6alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)-beta-D-glucopyranuronate
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
N-[(2R,3S)-2-[[[anilino(oxo)methyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide
1-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
3-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(3S,4aR,8aR)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
C32H45N3O4S (567.3130610000001)
[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
2-Amino-3-[2,3-di(decanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]propan-2-yl] propanoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
(5,9-Diacetyloxy-2,6,10-trimethyl-16-oxo-14-pyridin-3-yl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-dien-6-yl)methyl acetate
2-Amino-3-[hydroxy-(3-nonanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(2-heptadecanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(2-pentadecanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[(3-heptanoyloxy-2-tridecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-dodecanoyloxy-3-octanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-hexanoyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-hexadecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-octadecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
(E)-N-[2-[2-[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-3,4-dihydroxy-3,4-dihydro-2H-pyran-5-yl]dodec-2-enamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]propanamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundec-4-en-2-yl]acetamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]pentanamide
N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]butanamide
helvolate
The steroid acid anion formed by loss of a proton from the carboxy group of helvolic acid; major microspecies at pH 7.3.
1-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:6 in which the remaining acyl group is (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl.
N-tert-butyl-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide
C32H45N3O4S (567.3130610000001)
1-palmitoyl-2-glutaryl-sn-glycero-phosphoethanolamine
lysophosphatidylcholine 22:6
An acyl-sn-glycero-3-phosphocholine in which the acyl group (position not specified) contains 22 carbons with 6 double bonds.
1-Docosahexaenoyl-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:6 in which the docosahexaenoyl group is located at position 1.
2-docosahexaenoyl-sn-glycero-3-phosphocholine
A lysophosphatidylcholine 22:6 in which the acyl group is specified as docosahexaenoyl and is located at position 2.
chenodeoxycholic acid 24-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of chenodeoxycholic acid 24-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
deoxycholic acid 24-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of deoxycholic acid 24-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
hyodeoxycholic acid 24-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of hyodeoxycholic acid 24-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
(1s,2r,3r,4s,5r,6s,8r,9r,10r,13s,16s,17r,18r)-11-ethyl-8,18-dihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl (2e)-3-phenylprop-2-enoate
18-(acetyloxy)-11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
(1s,2r,3r,4s,5r,6s,8s,9s,10r,13s,16s,17r)-4-(acetyloxy)-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl benzoate
11-ethyl-8,9-dihydroxy-6,16,18-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 3-phenylprop-2-enoate
14-o-cinnamoylneoline
{"Ingredient_id": "HBIN001538","Ingredient_name": "14-o-cinnamoylneoline","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "C1=CC(=CN=C1)C2=CC3=NC(=NN3C(=N2)N)C4=CC=CO4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14681","TCMID_id": "3713","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
15-veratroyl-17-acetyl-19-oxodictizine
{"Ingredient_id": "HBIN001727","Ingredient_name": "15-veratroyl-17-acetyl-19-oxodictizine","Alias": "NA","Ingredient_formula": "C32H41NO8","Ingredient_Smile": "CC(=O)OCC1(C2CCC3(C1OC(=O)C4=CC(=C(C=C4)OC)OC)C5CC6C7(CCCC6(C3C2)C5N(C7=O)C)C)O","Ingredient_weight": "567.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22375","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21579305","DrugBank_id": "NA"}
2-deacetoxyl-10-acetoxytaxine b
{"Ingredient_id": "HBIN005495","Ingredient_name": "2-deacetoxyl-10-acetoxytaxine b","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26043","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetoxyl-9-acetoxytaxine b
{"Ingredient_id": "HBIN005496","Ingredient_name": "2-deacetoxyl-9-acetoxytaxine b","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26044","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetyl-10-acetyltaxine b
{"Ingredient_id": "HBIN005500","Ingredient_name": "2-deacetyl-10-acetyltaxine b","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4712","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetyl-9-acetoxytaxine b
{"Ingredient_id": "HBIN005502","Ingredient_name": "2-deacetyl-9-acetoxytaxine b","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4710","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-o-cinnamoylneoline
{"Ingredient_id": "HBIN013852","Ingredient_name": "8-o-cinnamoylneoline","Alias": "NA","Ingredient_formula": "C33H45NO7","Ingredient_Smile": "CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6CC4C5C6OC(=O)C=CC7=CC=CC=C7)OC)O)OC)O)COC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3712","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}